logo

CDXS

Codexis·NASDAQ
--
--(--)
--
--(--)
3.28 / 10
Netural

Fundamental assessment is neutral, scoring 3.3/10. Positive points include a low cost‑of‑sales ratio and strong interest coverage, yet debt‑to‑working‑capital and revenue growth are weak. Overall, the balance sheet shows modest strength, suggesting selective investment.

Fundamental(3.28)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value0.40
Score1/3
Weight18.02%
1M Return4.09%
Total operating revenue (YoY growth rate %)
Value18.61
Score1/3
Weight-1.42%
1M Return-0.38%
Inventory turnover ratio
Value5.16
Score2/3
Weight-4.14%
1M Return-1.18%
Current liabilities / Total liabilities (%)
Value26.03
Score3/3
Weight6.74%
1M Return1.67%
PB-ROE
Value-0.15
Score2/3
Weight33.84%
1M Return7.29%
Long-term debt to working capital ratio (%)
Value1.01
Score1/3
Weight-2.44%
1M Return-0.65%
Interest coverage ratio (EBIT / Interest expense) (%)
Value35.11
Score2/3
Weight-4.21%
1M Return-1.17%
Operating revenue (YoY growth rate %)
Value18.61
Score1/3
Weight-1.12%
1M Return-0.30%
Cost of sales ratio (%)
Value13.27
Score3/3
Weight1.05%
1M Return0.26%
Asset-MV
Value-0.55
Score2/3
Weight53.66%
1M Return11.12%
Is CDXS undervalued or overvalued?
  • CDXS scores 3.28/10 on fundamentals and holds a Fair valuation at present. Backed by its -74.88% ROE, -62.47% net margin, -3.76 P/E ratio, 3.27 P/B ratio, and 43.82% earnings growth, these metrics solidify its Netural investment rating.